These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2978890)
1. Three year experience of donor specific transfusion and concomitant cyclosporine A. Hillis AN; Duguid J; Evans CM; Bone JM; Sells RA Transplant Proc; 1987 Feb; 19(1 Pt 3):2248-9. PubMed ID: 2978890 [No Abstract] [Full Text] [Related]
2. Donor-specific T cell alloreactivity in relation to 1 haplotype-mismatched blood transfusion prior to living-donor renal transplantation. Bakran A; Taylor GM; Read I; Fergusson W; Johnson RW Transplant Proc; 1987 Feb; 19(1 Pt 1):748-9. PubMed ID: 2978929 [No Abstract] [Full Text] [Related]
3. Related donor kidney transplantation is the best form of treatment for uremia. Groth CG; Fehrman I; Ringdén O; Lundgren G Transplant Proc; 1987 Feb; 19(1 Pt 3):2278-9. PubMed ID: 2978893 [No Abstract] [Full Text] [Related]
4. The effects of donor specific transfusion and cyclosporine A on graft outcome. Haberal M; Oner Z; Aybasti N; Arslan G; Turan M; Bilgin N Transplant Proc; 1987 Feb; 19(1 Pt 3):2269-70. PubMed ID: 3274506 [No Abstract] [Full Text] [Related]
5. Immunosuppressive factors in patients after donor-specific transfusion with administration of cyclosporine. Yuzawa K; Otsuka M; Yu Y; Sharma N; Iwasaki H; Fukao K; Iwasaki Y Transplant Proc; 1991 Feb; 23(1 Pt 2):1036-8. PubMed ID: 1824884 [No Abstract] [Full Text] [Related]
6. Donor nonspecific blood transfusions before renal transplantation from haplo-mismatched living related donors. Shapira Z; Zamir R; Livni E; Yussim A; Shmueli D; Yehoshua H Transplant Proc; 1989 Feb; 21(1 Pt 2):1834-5. PubMed ID: 2652596 [No Abstract] [Full Text] [Related]
7. Changes in donor-specific cell-mediated lympholysis (CML) response associated with success of early steroid withdrawal in DST-azathioprine-treated renal transplant recipients. Burlingham WJ; Grailer A; Sollinger HW Transplant Proc; 1989 Feb; 21(1 Pt 2):1818-9. PubMed ID: 2523595 [No Abstract] [Full Text] [Related]
8. Donor-specific transfusion: a report of the Japanese Renal Transplant Registry. Sonoda T; Ishibashi M Clin Transpl; 1987; ():257-60. PubMed ID: 2978999 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of renal allografts by simultaneous cyclosporine and donor-specific blood transfusion. Francis DM; Masendycz PJ; Dumble LJ; Clunie GJ Transplant Proc; 1987 Feb; 19(1 Pt 2):1464-6. PubMed ID: 3274356 [No Abstract] [Full Text] [Related]
10. Renal transplantation from HLA-haploidentical living donors. Efficacy of cyclosporine in a multicenter study. Albrechtsen D; Flatmark A; Lundgren G; Brynger H; Frödin L; Groth C; Gäbel H; Thorsby E Transplant Proc; 1987 Oct; 19(5):3579-81. PubMed ID: 2960040 [No Abstract] [Full Text] [Related]
11. Effect of DST combined with cyclosporine on lymphocyte subsets of potential recipients for living-related donor renal allograft. Murai M; Nakamura H; Sekiguchi S; Shimizu S; Nakajima F Transplant Proc; 1994 Aug; 26(4):1950-1. PubMed ID: 8066631 [No Abstract] [Full Text] [Related]
12. Optimization of donor specific blood transfusion in kidney transplantation. Cheigh JS; Suthanthiran M; Stubenbord WT; Fotino M; Riggio RR; Schechter N; Stenzel KH; Rubin AL Transplant Proc; 1987 Feb; 19(1 Pt 3):2250-1. PubMed ID: 2978891 [TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation. Bordes-Aznar J; Odor A; Dib-Kuri A; Gabilondo F; Kasep J; Peña JC; Herrera-Acosta J; Chávez-Peón F Transplant Proc; 1987 Feb; 19(1 Pt 3):2276-7. PubMed ID: 3079080 [No Abstract] [Full Text] [Related]
14. Antiidiotypic activity and sensitization after donor-specific transfusion (DST) given with and without cyclosporin A (CsA). Hillis AN; MacLeod AM; al-Muzairai IA; Innes A; Stewart KN; Power DA; Bone MJ; Sells RA; Catto GR Transplant Proc; 1989 Feb; 21(1 Pt 2):1820-1. PubMed ID: 2652591 [No Abstract] [Full Text] [Related]
16. Outcome of kidney transplantation in highly sensitized patients after donor-specific blood transfusion. Takahashi K; Yagisawa T; Tanabe I; Teraoka S; Hayasaka Y; Yasuo M; Fuchinoue S; Honda H; Toma H; Agishi T Transplant Proc; 1987 Oct; 19(5):3655-60. PubMed ID: 2960043 [No Abstract] [Full Text] [Related]
17. Comparison between prophylactic use of OKT3 and cyclosporine in cadaveric renal transplantation. De Pauw L; Abramowicz D; Goldman M; Vereerstraeten P; Kinnaert P; Toussaint C Transplant Proc; 1990 Aug; 22(4):1759-60. PubMed ID: 2117800 [No Abstract] [Full Text] [Related]
18. In-vitro mechanisms responsible for prolonged rat cardiac allograft survival induced by ultraviolet irradiated donor-specific blood and cyclosporine. Oluwole SF; Chabot J; Pepino P; Reemtsma K; Hardy MA Transplant Proc; 1987 Oct; 19(5):4331-3. PubMed ID: 2960059 [No Abstract] [Full Text] [Related]